In order to treat urge and mixed urine incontinence, Amber Therapeutics, an Oxford University spin-off firm that is researching next-generation bioelectrical therapeutics, has implanted Amber-UI in the first participants (UI).
According to the most recent UN estimate made public by the United Nations Inter-agency Group for Child Mortality Estimation, 2.1 million children and youth aged between 5 and 24 years and 5 million children and youth under the age of five died in 2021.
Acute malnutrition affects more than 30 million children in the 15 countries that are most severely affected. Severe wasting, the deadliest form of undernutrition, affects 8 million of these children. This poses a serious risk to children’s lives, long-term health, and development, and it has an effect on every person, every community, and every nation.
9 January (Reuters) AstraZeneca (AZN.L) declared on Monday that it has reached an agreement to acquire American drug-development company CinCor Pharma Inc (CINC.O) for up to $1.8 billion in order to expand its supply of heart and kidney medications.
The experimental medication baxdrostat, which is being developed by CinCor to treat illnesses like high blood pressure and chronic renal disease, is at the heart of the agreement.
Adar Poonawalla, chief executive officer of Serum Institute of India, stated on Sunday that the Covovax vaccine will be approved as a booster in the upcoming 10 to 15 days and added that it is effective against the Omicron form of coronavirus.
By 2030, the goal of the collaboration will be to provide 10,000 patients their own mRNA. A partnership between BioNTech and the UK government has been announced with the objective of hastening the development of individualized mRNA immunotherapies.
During the two years of the pandemic, sales of the Covid-19 portfolio of drugs skyrocketed, resulting in severe shortages at times. However, the industry is now saddled with a massive inventory of raw materials and medicines used in Covid-19, as well as potential losses and write-offs in the hundreds of crores.
Pfizer, a US pharmaceutical company, has established a global drug development centre at the Indian Institute of Technology-Madras Research Park here, at a cost of more than Rs 150 crore. The facility, which will employ 250 scientists and technicians, will create novel formulations, small molecules, and active pharmaceutical ingredients (APIs).
On the edge of Hyderabad in southern India, a vast patch of arid shrub-land the size of about 14,000 football fields is becoming a testing ground for a model that could help wean the world off its dependence on Chinese drug ingredients.
Covax has delivered 1.42 billion doses to 145 countries. Scaling up deliveries through Covax is seen as critical to meeting a WHO target to vaccinate 70% of the population in poorer nations by mid-2022
